EMILY AMOS: Open Payments
NPI 1043707441 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 22 payments from 9 companies in 2025. Trend: 2023 $929 · 2024 $794 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $153 |
| Novo Nordisk Inc | 5 | $98 |
| Exact Sciences Corporation | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
Products named: REPATHA, Cologuard Collection Kit, Ozempic, Rybelsus, JARDIANCE, TRELEGY ELLIPTA, INSPIRE, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
